Workflow
天坛生物(600161) - 2024 Q2 - 季度业绩
BTBPBTBP(SH:600161)2024-07-12 09:33

Financial Performance - Total operating revenue for the first half of 2024 increased by 5.59% compared to the same period last year, reaching ¥284,137.44 million[3] - Net profit attributable to shareholders of the listed company rose by 28.12% year-on-year, amounting to ¥72,621.18 million[3] - Basic earnings per share increased by 28.12% to ¥0.37[3] - The net profit excluding non-recurring gains and losses increased by 29.43% to ¥72,363.45 million[3] Assets and Equity - Total assets at the end of the reporting period grew by 6.74% to ¥1,514,444.23 million[3] - The company's equity attributable to shareholders increased by 5.02% to ¥1,031,575.13 million[3] - The number of shares outstanding increased by 20.00% to 197,737.14 million shares[3] Profitability and Efficiency - The weighted average return on equity improved by 1.10 percentage points to 7.34%[3] - The company reported improved profit margins due to better control of product pricing and cost management[5] Reporting Integrity - There are no uncertainties affecting the accuracy of this performance report[5]